Assessment, diagnosis and treatment of a patient with hirsutism

Nature Clinical Practice Endocrinology and Metabolism

Volumn 4, Issue 5, 2008, Pages 294-300

  Yildiz, Bulent O ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Androgen excess; Antiandrogens; Hyperandrogenemia; Insulin sensitizers; Oral contraceptives

Indexed keywords

CYPROTERONE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROGESTERONE; PROLACTIN; SPIRONOLACTONE; TESTOSTERONE; THYROTROPIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL ASSESSMENT; DOPPLER ECHOGRAPHY; ESTHETIC SURGERY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HAIR; HIRSUTISM; HORMONE DETERMINATION; HUMAN; KIDNEY FUNCTION TEST; LIPID METABOLISM; LIVER FUNCTION TEST; MENARCHE; MENSTRUAL IRREGULARITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VITAL SIGN;

ADULT; ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; ETHINYL ESTRADIOL; FEMALE; HIRSUTISM; HUMANS; POLYCYSTIC OVARY SYNDROME; SPIRONOLACTONE;

EID: 42449105290     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0789     Document Type: Article

References (15)

1. Sonino N et al. (1993) Quality of life of hirsute women. Postgrad Med J 69: 186-189
2. Yildiz BO (2006) Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 20: 167-176
3. Azziz R et al. (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89: 453-462
4. Rittmaster RS (1997) Hirsutism. Lancet 349: 191-195
5. Ewing JA et al. (1978) Hirsutism, race and testosterone levels: comparison of East Asians and Euroamericans. Hum Biol 50: 209-215
6. Hatch R et al. (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140: 815-830
7. Yildiz BO (2007) Hormonal and biochemical evaluation of polycystic ovary syndrome. In Contemporary Endocrinology: Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment, 241-248 (Eds Nestler JE et al.) Totowa, NJ: Humana Press
8. Rosner W et al. (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92: 405-413
9. Legro RS et al. (2006) The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86: 914-933
10. Zawadzki JK et al. (1992) Diagnostic criteria for polycystic ovary syndrome. In Polycystic ovary syndrome, 377-384 (Eds Dunaif A et al.) Boston, MA: Blackwell Scientific Publications
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25
12. Azziz R et al. (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237-4245
13. Yildiz BO (2004) Recent advances in the treatment of polycystic ovary syndrome. Expert Opin Investig Drugs 13: 1295-1305
14. Carmina E (2002) Anti-androgens for the treatment of hirsutism. Expert Opin Investig Drugs 11: 357-363
15. Costello MF et al. (2007) Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 22: 1200-1209